These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11803519)

  • 1. Patterns of dysmorphic features in schizophrenia.
    Scutt LE; Chow EW; Weksberg R; Honer WG; Bassett AS
    Am J Med Genet; 2001 Dec; 105(8):713-23. PubMed ID: 11803519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 22q11 deletion syndrome: a genetic subtype of schizophrenia.
    Bassett AS; Chow EW
    Biol Psychiatry; 1999 Oct; 46(7):882-91. PubMed ID: 10509171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microdeletion 22q11: apropos of case of schizophrenia in an adolescent].
    Pinquier C; Héron D; de Carvalho W; Lazar G; Mazet P; Cohen D
    Encephale; 2001; 27(1):45-50. PubMed ID: 11294038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two Patterns of White Matter Abnormalities in Medication-Naive Patients With First-Episode Schizophrenia Revealed by Diffusion Tensor Imaging and Cluster Analysis.
    Sun H; Lui S; Yao L; Deng W; Xiao Y; Zhang W; Huang X; Hu J; Bi F; Li T; Sweeney JA; Gong Q
    JAMA Psychiatry; 2015 Jul; 72(7):678-86. PubMed ID: 25993492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder.
    Fernandez BA; Roberts W; Chung B; Weksberg R; Meyn S; Szatmari P; Joseph-George AM; Mackay S; Whitten K; Noble B; Vardy C; Crosbie V; Luscombe S; Tucker E; Turner L; Marshall CR; Scherer SW
    J Med Genet; 2010 Mar; 47(3):195-203. PubMed ID: 19755429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anthropometric assessment of dysmorphic features in schizophrenia as an index of its developmental origins.
    Lane A; Kinsella A; Murphy P; Byrne M; Keenan J; Colgan K; Cassidy B; Sheppard N; Horgan R; Waddington JL; Larkin C; O'Callaghan E
    Psychol Med; 1997 Sep; 27(5):1155-64. PubMed ID: 9300519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct Patterns of Cerebral Cortical Thinning in Schizophrenia: A Neuroimaging Data-Driven Approach.
    Sugihara G; Oishi N; Son S; Kubota M; Takahashi H; Murai T
    Schizophr Bull; 2017 Jul; 43(4):900-906. PubMed ID: 28008071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cluster analysis of obsessive-compulsive spectrum disorders in patients with obsessive-compulsive disorder: clinical and genetic correlates.
    Lochner C; Hemmings SM; Kinnear CJ; Niehaus DJ; Nel DG; Corfield VA; Moolman-Smook JC; Seedat S; Stein DJ
    Compr Psychiatry; 2005; 46(1):14-9. PubMed ID: 15714189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Velo-cardio-facial syndrome: Implications of microdeletion 22q11 for schizophrenia and mood disorders.
    Arnold PD; Siegel-Bartelt J; Cytrynbaum C; Teshima I; Schachar R
    Am J Med Genet; 2001 May; 105(4):354-62. PubMed ID: 11378850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracardiac features predicting 22q11.2 deletion syndrome in adult congenital heart disease.
    Fung WL; Chow EW; Webb GD; Gatzoulis MA; Bassett AS
    Int J Cardiol; 2008 Dec; 131(1):51-8. PubMed ID: 18191243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtelomeric chromosomal rearrangements detected in patients with idiopathic mental retardation and dysmorphic features.
    Caliskan MO; Karauzum SB; Mihci E; Tacoy S; Luleci G
    Genet Couns; 2005; 16(2):129-38. PubMed ID: 16080292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of induced pluripotent stem cells carrying 22q11.2 deletion.
    Toyoshima M; Akamatsu W; Okada Y; Ohnishi T; Balan S; Hisano Y; Iwayama Y; Toyota T; Matsumoto T; Itasaka N; Sugiyama S; Tanaka M; Yano M; Dean B; Okano H; Yoshikawa T
    Transl Psychiatry; 2016 Nov; 6(11):e934. PubMed ID: 27801899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An Adult Case of 22q11.2 Deletion Syndrome with Congenital Abnormalities and Neurodevelopmental Disorders, Which Remained Undiagnosed Until Presentation of Auditory Hallucinations].
    Tamune H; Nishimura F; Koshiyama D; Yamada K; Kondo S; Kano Y; Kasai K
    Seishin Shinkeigaku Zasshi; 2017; 119(1):9-16. PubMed ID: 30629863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-Genome Sequencing Suggests Schizophrenia Risk Mechanisms in Humans with 22q11.2 Deletion Syndrome.
    Merico D; Zarrei M; Costain G; Ogura L; Alipanahi B; Gazzellone MJ; Butcher NJ; Thiruvahindrapuram B; Nalpathamkalam T; Chow EW; Andrade DM; Frey BJ; Marshall CR; Scherer SW; Bassett AS
    G3 (Bethesda); 2015 Sep; 5(11):2453-61. PubMed ID: 26384369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune defects in subjects with dysmorphic disorders.
    Mahmoud SA; Lowery-Nordberg M; Chen H; Thurmon T; Ursin S; Bahna SL
    Allergy Asthma Proc; 2005; 26(5):373-81. PubMed ID: 16450572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome.
    Bassett AS; Marshall CR; Lionel AC; Chow EW; Scherer SW
    Hum Mol Genet; 2008 Dec; 17(24):4045-53. PubMed ID: 18806272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon Family Study.
    Kendler KS; McGuire M; Gruenberg AM; Walsh D
    Am J Psychiatry; 1995 May; 152(5):755-64. PubMed ID: 7726316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening of patients at risk for 22q11 deletion.
    Barisić I; Morozin Pohovski L; Petković I; Cvetko Z; Stipancić G; Bagatin M
    Coll Antropol; 2008 Mar; 32(1):165-9. PubMed ID: 18494202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High resolution cytogenetic study in schizophrenia.
    Casacchia M; Brisdelli F; de Cataldo S; Rossi A; d'Alessandro E
    Ann Genet; 1996; 39(3):144-6. PubMed ID: 8839886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of 30 patients with unexplained developmental delay and dysmorphic features or congenital abnormalities using conventional cytogenetics and multiplex FISH telomere (M-TEL) integrity assay.
    Popp S; Schulze B; Granzow M; Keller M; Holtgreve-Grez H; Schoell B; Brough M; Hager HD; Tariverdian G; Brown J; Kearney L; Jauch A
    Hum Genet; 2002 Jul; 111(1):31-9. PubMed ID: 12136233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.